There is no commercial support for this activity.

About the speaker

Robert D. Gibbons is the Blum-Riese Professor and a Pritzker Scholar at the University of Chicago. He has appointments in the Departments of Medicine, Public Health Sciences and Comparative Human Development. He also directs the Center for Health Statistics. Professor Gibbons is a Fellow of the American Statistical Association, the International Statistical Institute, and the Royal Statistical Society, and a member of the National Academy of Medicine of the National Academy of Sciences. He has authored more than 300 peer-reviewed scientific papers and five books. His statistical work spans the areas of longitudinal data analysis, item response theory, environmental statistics and drug safety and has led to thousands of applications in the biological and social sciences. Professor Gibbons has received life-time achievement awards from the American Statistical Association, the American Public Health Association and Harvard University. He is a founder of the Mental Health Statistics section of the American Statistical Association.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, selling, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Robert D. Gibbons, PhD, reports that he receives founder shares of stock for Adaptive Testing Technologies. He will be discussing the the science underlying the CAT-MH. He will not be discussing any off-label uses of pharmaceuticals. All conflicts have been mitigated through review. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.